NCT00021229 2014-07-31Imatinib Mesylate With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed or Recurrent GliomaNational Cancer Institute (NCI)Phase 1/2 Terminated85 enrolled 17 charts
NCT00154375 2011-04-26Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive GlioblastomaNovartisPhase 3 Completed240 enrolled 8 charts